Terms: = Head and neck cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Diagnosis
17 results:
1. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
[TBL] [Abstract] [Full Text] [Related]
2. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.
Sepulveda JL; Komissarova EV; Kongkarnka S; Friedman RA; Davison JM; Levy B; Bryk D; Jobanputra V; Del Portillo A; Falk GW; Sonett JR; Lightdale CJ; Abrams JA; Wang TC; Sepulveda AR
Int J Cancer; 2019 Nov; 145(10):2754-2766. PubMed ID: 31001805
[TBL] [Abstract] [Full Text] [Related]
3. In silico analysis of fragile histidine triad involved in regression of carcinoma.
Rasheed MA; Tariq F; Afzal S; Mannanv S
J Pak Med Assoc; 2017 Apr; 67(4):616-621. PubMed ID: 28420927
[TBL] [Abstract] [Full Text] [Related]
4. Expression of fhit, p16, p53 and EGFR as prognostic markers in thyroid tumors of uncertain malignant potential.
Koc M; Aktimur R; Kagan Gokakin A; Atabey M; Koyuncu A; Elagoz S; Topcu O
J BUON; 2015; 20(2):567-72. PubMed ID: 26011351
[TBL] [Abstract] [Full Text] [Related]
5. Genetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinoma-the first step towards clinical personalized medicine.
Ribeiro IP; Marques F; Caramelo F; Ferrão J; Prazeres H; Julião MJ; Rifi W; Savola S; de Melo JB; Baptista IP; Carreira IM
Tumour Biol; 2014 May; 35(5):4687-95. PubMed ID: 24477574
[TBL] [Abstract] [Full Text] [Related]
6. Distinct effects of alcohol consumption and smoking on genetic alterations in head and neck carcinoma.
Urashima M; Hama T; Suda T; Suzuki Y; Ikegami M; Sakanashi C; Akutsu T; Amagaya S; Horiuchi K; Imai Y; Mezawa H; Noya M; Nakashima A; Mafune A; Kato T; Kojima H
PLoS One; 2013; 8(11):e80828. PubMed ID: 24278325
[TBL] [Abstract] [Full Text] [Related]
7. Expression of fragile histidine triad (fhit) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma.
Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2013; 14(1):165-71. PubMed ID: 23534718
[TBL] [Abstract] [Full Text] [Related]
8. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors.
Wang O; Wang CY; Shi J; Nie M; Xia WB; Li M; Jiang Y; Guan H; Meng XW; Xing XP
Chin Med J (Engl); 2012 Aug; 125(16):2895-901. PubMed ID: 22932087
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
[TBL] [Abstract] [Full Text] [Related]
10. Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions.
Shumway BS; Kresty LA; Larsen PE; Zwick JC; Lu B; Fields HW; Mumper RJ; Stoner GD; Mallery SR
Clin Cancer Res; 2008 Apr; 14(8):2421-30. PubMed ID: 18413833
[TBL] [Abstract] [Full Text] [Related]
11. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area.
Guo XQ; Wang SJ; Zhang LW; Wang XL; Zhang JH; Guo W
J Exp Clin Cancer Res; 2007 Dec; 26(4):587-94. PubMed ID: 18365557
[TBL] [Abstract] [Full Text] [Related]
12. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.
Thomas GR; Nadiminti H; Regalado J
Int J Exp Pathol; 2005 Dec; 86(6):347-63. PubMed ID: 16309541
[TBL] [Abstract] [Full Text] [Related]
13. Surgical treatment of malignant esophageal tumors in PUMC Hospital.
Guo H; Li Z; Zhang F; Zhang Z; Xu L; Li W; Wang W; Wu M
Chin Med Sci J; 2001 Dec; 16(4):214-7. PubMed ID: 12903759
[TBL] [Abstract] [Full Text] [Related]
14. [Surgical treatment of malignant esophageal tumors in PUMC Hospital].
Guo H; Li Z; Zhang Z; Sun C; Xu L; Li W; Wang S; Wu M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):548-50. PubMed ID: 12903401
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of the tumour suppressor genes, fhit and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
Nagel H; Laskawi R; Eiffert H; Schlott T
Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744
[TBL] [Abstract] [Full Text] [Related]
16. Aggressive management of second primary tumors in survivors of hereditary retinoblastoma.
Smith LM; Donaldson SS; Egbert PR; Link MP; Bagshaw MA
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):499-505. PubMed ID: 2777644
[TBL] [Abstract] [Full Text] [Related]
17. Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients.
Tennvall J; Biörklund A; Johansson L; Akerman M
Eur J Surg Oncol; 1989 Feb; 15(1):1-9. PubMed ID: 2917660
[TBL] [Abstract] [Full Text] [Related]
